Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. 

Product information

Vectormune FP ILT : EPAR - Product Information

English (EN) (81.49 KB - PDF)

First published: Last updated:
View

български (BG) (91.78 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

español (ES) (81.51 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

čeština (CS) (92.48 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

dansk (DA) (82.05 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Deutsch (DE) (81.72 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

eesti keel (ET) (81.22 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

ελληνικά (EL) (91.79 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

français (FR) (81.63 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

hrvatski (HR) (91.56 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

íslenska (IS) (81.52 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Gaeilge (GA) (81.36 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

italiano (IT) (81.76 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

latviešu valoda (LV) (92.14 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

lietuvių kalba (LT) (92.19 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

magyar (HU) (92.76 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Malti (MT) (93.86 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Nederlands (NL) (81.15 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

norsk (NO) (81.52 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

polski (PL) (93.22 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

português (PT) (82.53 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

română (RO) (91.73 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

slovenčina (SK) (81.75 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

slovenščina (SL) (81.76 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Suomi (FI) (81.11 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

svenska (SV) (81.47 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Vectormune FP ILT : EPAR - All authorised presentations

English (EN) (81.94 KB - PDF)

First published: Last updated:
View

български (BG) (93.36 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

español (ES) (81.97 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

čeština (CS) (93.99 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

dansk (DA) (83.34 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Deutsch (DE) (82.76 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

eesti keel (ET) (82.18 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

ελληνικά (EL) (93.76 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

français (FR) (82.44 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

hrvatski (HR) (92.27 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

íslenska (IS) (83.29 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Gaeilge (GA) (83.57 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

italiano (IT) (82.29 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

latviešu valoda (LV) (94.29 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

lietuvių kalba (LT) (94.03 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

magyar (HU) (94.15 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Malti (MT) (95.95 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Nederlands (NL) (82.05 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

norsk (NO) (82 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

polski (PL) (95.62 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

português (PT) (83.01 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

română (RO) (94.17 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

slovenčina (SK) (94.08 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

slovenščina (SL) (82.27 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Suomi (FI) (81.54 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

svenska (SV) (82.05 KB - PDF)

First published: 10/09/2021Last updated: 27/05/2024
View

Product details

Name of medicine
Vectormune FP ILT
Active substance
recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live
International non-proprietary name (INN) or common name
Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Pharmacotherapeutic group

Immunologicals for aves

Authorisation details

EMA product number
EMEA/V/C/005482

Assessment history

Vectormune FP ILT : EPAR - Public assessment report

AdoptedReference Number: EMA/565679/2020

English (EN) (81.49 KB - PDF)

First published: Last updated:
View

CVMP summary of positive opinion for Vectormune FP ILT

AdoptedReference Number: EMA/CVMP/505185/2020

English (EN) (132.19 KB - PDF)

First published:
View
This page was last updated on

Share this page